Circulating level of α2-macroglobulin–β2-microglobulin complex in hemodialysis patients
- 1 December 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (6) , 2244-2252
- https://doi.org/10.1046/j.1523-1755.2003.00315.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Antiproteases and Cells in the Pathogenesis of β2-Microglobulin Amyloidosis: Role of α2-Macroglobulin and MacrophagesNephron, 2000
- Histological characteristics of sternoclavicular β2-microglobulin amyloidosis and clues for its histogenesisKidney International, 1999
- N -(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosisKidney International, 1998
- α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related ProteinJournal of Neurochemistry, 1997
- α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma ProteinJournal of Neurochemistry, 1997
- α2-Macroglobulin Protects Some of the Protein Constituents of Dialysis-Associated Amyloidosis from Protease DegradationBiochemical and Biophysical Research Communications, 1997
- Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 alleleAmyloid, 1997
- An estimate of β2-microglobulin deposition rate in uremic patients on hemodialysis using a mathematical kinetic modelKidney International, 1995
- Demonstration of plasma proteinase inhibitors in β2-microglobulin amyloid depositsKidney International, 1992
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986